Fresenius acquires full ownership of mAbxience
Fresenius's acquisition of full ownership of mAbxience for up to 750 million euros is positive, as it gives the German healthcare group greater exposure to a growing market, Citi analysts write in a research note.
Fresenius’s move to take full ownership of mAbxience for up to 750 million euros is seen as positive, Citi analysts said in a research note, saying it would give the German healthcare group greater exposure to a growing market. The analysts said the acquisition should strengthen Fresenius’s position in the bi…